Auteur J. G. BRAMNESS

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Les addictions, c'est comment ailleurs ? Aujourd'hui : la Norvège

J. G. BRAMNESS, Personne interviewée ; B. ROLLAND, Intervieweur | 2019
Dans Flyer (Le) (n°76, Octobre 2019) Article : Périodique

Après différents voyages en Australie, en Italie et en Inde, Benjamin Rolland nous emmène cette fois plus au nord, dans un pays scandinave, la Norvège. Le pays a pu recevoir dans le passé beaucoup de critiques, notamment sur son accès aux MSO, t[...]

Plus d'info

Ajouter à la sélection

Lien externe

A bibliometric analysis of European versus USA research in the field of addiction. Research on alcohol, narcotics, prescription drug abuse, tobacco and steroids 2001-2011

J. G. BRAMNESS ; B. HENRIKSEN ; O. PERSON ; K. MANN | 2014
Dans European Addiction Research (Vol.20, n°1, January 2014) Article : Périodique

Background: To compare the publication and citation rate within the areas of drug abuse and dependence research in Europe with that in the USA. Methods: This is a bibliometric study using the Thomson Reuters Web of Knowledge as data source, 40[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

A comparison between wastewater-based drug data and an illicit drug use survey in a selected community

J. H. P. VAN WEL ; J. KINYUA ; A. L. N. VAN NUIJS ; S. SALVATORE ; J. G. BRAMNESS ; A. COVACI ; G. VAN HAL | 2016
Dans International Journal of Drug Policy (Vol.34, August 2016) Article : Périodique

Background: Estimations of drug use are mostly based on population surveys that can suffer from response biases. The current study evaluates using wastewater-based epidemiology (WBE) for assessing illicit drug use by comparing wastewater data wi[...]

Plus d'info

Ajouter à la sélection

Comparison of European clinical guidelines on the management of alcohol use disorders

C. DRUMMOND ; M. HILLYARD ; M. LEONHARDT ; F. WURST ; G. DOM ; K. MANN ; J. G. BRAMNESS | 2021
Dans European Addiction Research (Vol.27, n°3, May 2021) Article : Périodique

BACKGROUND: Alcohol is a leading cause of morbidity and mortality in the European region, and tackling the harmful use of alcohol is a public health priority. Most countries in the region have national strategies for treating alcohol use disorde[...]

Plus d'info

Ajouter à la sélection

Delta9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users

J. MORLAND ; J. G. BRAMNESS | 2020
Dans Forensic Science International (Vol.309, April 2020) Article : Périodique

Background: THC can be measured in blood up to a month after last intake in heavy cannabis users. The cognitive deficits during abstinence have been hypothesized to be at least in part due to residual THC in brain. To which extent THC accumulati[...]

Plus d'info

Ajouter à la sélection

Education and training in addiction medicine and psychology across Europe: A EUFAS Survey

J. G. BRAMNESS ; M. LEONHARDT ; G. DOM ; A. BATALLA ; G. FLOREZ MENENDEZ ; K. MANN ; F. M. WURST ; M. WOJNAR ; C. DRUMMOND ; E. SCAFATO ; A. GUAL ; C. M. RIBEIRO ; O. COTTENCIN ; U. FRISCHKNECHT ; B. ROLLAND | 2024
Dans European Addiction Research (Vol.30, n°3, July 2024) Article : Périodique

INTRODUCTION: Training in addiction medicine and addiction psychology is essential to ensure the quality of treatment for patients with substance use disorders. Some earlier research has shown varying training between countries, but no comprehen[...]

Plus d'info

Ajouter à la sélection

Lien externe

Impairment due to intake of carisoprodol

J. G. BRAMNESS ; S. SKURTVEIT ; J. MORLAND | 2004
Périodique

ENGLISH : Background: Carisoprodol is a centrally acting muscle relaxant commonly used for lower back pain. It is a drug of abuse and has been detected among impaired drivers. Carisoprodol's active metabolite meprobamate is thought to act thro[...]

Plus d'info

Ajouter à la sélection

On the duration of cannabis effects and the presence of THC in the body

J. MORLAND ; A. L. BRETTEVILLE-JENSEN ; J. G. BRAMNESS | 2023
Dans Addiction (Vol.118, n°2, February 2023) Article : Périodique

When tetrahydrocannabinol (THC), the most important psychoactive ingredient in cannabis, is present in sufficiently high concentrations it affects brain function. It is important to know the duration of this effect, both for medical and recreati[...]

Plus d'info

Ajouter à la sélection

Lien externe

A survey on the medical use of cannabis in Europe: A position paper

J. G. BRAMNESS ; G. DOM ; A. GUAL ; K. MANN ; F. M. WURST | 2018
Dans European Addiction Research (Vol.24, n°4, August 2018) Article : Périodique

AIM: This study was aimed at investigating the availability and prescription of different medicinal variants of cannabis and their status in European countries. METHODS: A web-based survey was sent to all member societies of the -European Feder[...]

Plus d'info

Ajouter à la sélection

Wastewater-based epidemiology of stimulant drugs: Functional data analysis compared to traditional statistical methods

S. SALVATORE ; J. G. BRAMNESS ; M. J. REID ; K. V. THOMAS ; C. HARMAN ; J. ROISLIEN | 2015
Dans PLOS ONE (Vol.10, n°9, September 2015) Article : Périodique

BACKGROUND: Wastewater-based epidemiology (WBE) is a new methodology for estimating the drug load in a population. Simple summary statistics and specification tests have typically been used to analyze WBE data, comparing differences between week[...]

Plus d'info

Ajouter à la sélection

Lien externe